Tyra biosciences to present at upcoming investor conferences

Carlsbad, calif. , nov. 13, 2024 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that company management will participate in the following investor conferences: jefferies london healthcare conference, november 19-21st, 2024:  todd harris, ceo of tyra, will participate in a fireside chat on tuesday, november 19th, at 2:00 pm gmt.
TYRA Ratings Summary
TYRA Quant Ranking